Spectranetics (NSDQ:SPNC) said today that it’s Stellarex drug-coated balloon won FDA pre-market approval.
The device is designed to treat patients with peripheral arterial disease, bringing blood flow back to the superficial femoral and popliteal arteries.
Get the full story at our sister site, Drug Delivery Business News.
The post Spectranetics wins FDA nod for Stellarex DCB appeared first on MassDevice.
from MassDevice http://ift.tt/2tFZz1u
Cap comentari:
Publica un comentari a l'entrada